A response to pharmacological intervention was defined as a decrease in ALT of >30% compared with baseline after 6 months of PEM treatment according to several NAFLD clinical trials [21,22]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.